A 10-year-old child with von Willebrand's disease is scheduled for a dental extraction. Which nursing intervention is most appropriate to prepare this child for the procedure?
The nurse is caring for a pediatric patient with von Willebrand's disease who requires dental surgery.
1Administer aspirin 30 minutes before the procedure to prevent pain
2Coordinate with the physician to administer desmopressin (DDAVP) before the procedure✓ 정답
3Apply ice packs to the jaw area immediately before the procedure
4Encourage the child to rinse with hydrogen peroxide solution
해설
Children with von Willebrand's disease have a bleeding disorder that requires specific preparation before invasive procedures. Desmopressin (DDAVP) is the treatment of choice as it increases von Willebrand factor and factor VIII levels, reducing bleeding risk during dental procedures.
Von Willebrand disease is the most common inherited bleeding disorder, affecting approximately 1% of the population. It is caused by a deficiency or dysfunction of von Willebrand factor (vWF), a protein essential for normal blood clotting. For children with this condition, even minor procedures such as dental extractions can cause serious bleeding complications.
Pathophysiologically, von Willebrand factor plays a dual role in the hemostatic process. It promotes platelet adhesion to damaged blood vessel walls and serves as a carrier protein for factor VIII. When vWF is deficient or dysfunctional, both primary hemostasis (platelet plug formation) and secondary hemostasis (coagulation cascade) are impaired.
Desmopressin (DDAVP) is the first-line treatment for patients with von Willebrand disease, especially those with type 1 (the mildest and most common form). DDAVP works by stimulating the release of von Willebrand factor and factor VIII from endothelial cells and platelets. When administered before invasive procedures, it can increase vWF levels by 3-5 times within 30-60 minutes, significantly reducing bleeding risk.
The timing of DDAVP administration is critical for optimal effect. It should be given 30-60 minutes before the procedure to allow sufficient time for vWF levels to rise. Nurses must collaborate with physicians to ensure appropriate timing and dosage. For dental procedures, DDAVP is often used in combination with antifibrinolytic agents such as tranexamic acid to further reduce bleeding risk.
Nursing considerations include monitoring for potential side effects of DDAVP such as facial flushing, headache, and rarely, hyponatremia due to water retention. Nurses should also educate families about post-procedure care, including avoiding aspirin-containing medications and monitoring for signs of excessive bleeding.
The most appropriate nursing intervention is to coordinate with the physician to administer desmopressin (DDAVP) before the procedure. Von Willebrand disease (VWD) is characterized by a deficiency or dysfunction of von Willebrand factor (VWF), a protein critical for platelet adhesion and aggregation at sites of vascular injury [1]. Dental extractions create a significant hemostatic challenge because the oral mucosa is highly vascular, and saliva contains fibrinolytic enzymes that can dissolve clots. Without preoperative hemostatic coverage, a patient with VWD is at high risk for prolonged, potentially life-threatening intraoperative or postoperative bleeding [1].
Desmopressin (DDAVP) is a synthetic analog of vasopressin that works by stimulating endothelial cells to release stored VWF and factor VIII into the circulation. This transiently raises the patient's own functional VWF levels, thereby correcting the hemostatic defect for the duration of the surgical procedure. The rationale for this intervention is grounded in the standard of care for managing patients with mild bleeding disorders during invasive procedures, where preoperative pharmacological prophylaxis is used to individualize and optimize hemostasis [2]. A systematic review of perioperative bleeding management confirms that for patients with inherited bleeding disorders, the cornerstone of safe procedural planning is the preemptive administration of targeted hemostatic agents based on the specific defect [3]. Coordinating this intervention is a direct nursing responsibility that bridges the medical order with timely, safe preoperative preparation.
In-Depth Analysis of Incorrect Options
Option 1: Administer aspirin 30 minutes before the procedure to prevent pain.
This action is contraindicated. Aspirin irreversibly inhibits platelet cyclooxygenase, blocking thromboxane A2 production and thereby impairing platelet aggregation. In a patient with VWD, whose platelets already have a primary adhesion defect due to the lack of functional VWF, adding an aspirin-induced aggregation defect would compound the bleeding risk and could precipitate catastrophic hemorrhage [1,3]. Pain management in these patients must rely on non-NSAID, non-antiplatelet analgesics.
Option 3: Apply ice packs to the jaw area immediately before the procedure.
While cold application causes local vasoconstriction and is a useful adjuvant for managing superficial bleeding or post-procedural swelling, it is not a primary hemostatic intervention. Vasoconstriction alone cannot compensate for the profound defect in platelet plug formation caused by a lack of functional VWF. Applying ice preoperatively does not address the underlying coagulopathy and would provide a false sense of security, leaving the patient vulnerable to uncontrolled bleeding once the surgical incision is made [1,3].
Option 4: Encourage the child to rinse with hydrogen peroxide solution.
Hydrogen peroxide rinses are sometimes used for oral debridement, but they have no role in preventing surgical bleeding in a patient with a known bleeding disorder. In fact, the effervescent action of peroxide can dislodge any forming fibrin clot and may interfere with wound healing. Recommending this as a preoperative intervention neglects the critical need for systemic hemostatic prophylaxis and could disrupt clot formation at the surgical site [1,4].
Integrated Pathophysiology and Clinical Application
The underlying pathophysiology of VWD directly informs the nursing priority. VWF has two main hemostatic functions: it acts as a bridge between exposed subendothelial collagen and platelet glycoprotein Ib receptors during platelet adhesion, and it serves as a carrier protein for factor VIII, protecting it from proteolytic degradation. A quantitative or qualitative defect in VWF therefore leads to defective platelet plug formation and a secondary reduction in factor VIII activity, impairing both primary and secondary hemostasis [1,4]. The surgical trauma of a dental extraction disrupts blood vessels, exposing collagen and tissue factor. In a healthy individual, VWF immediately mediates platelet adhesion to form the initial plug, which is then stabilized by the coagulation cascade. In a child with VWD, this initial step fails, leading to continuous oozing that is resistant to standard local measures [1].
The evidence supports a risk-stratified, individualized approach to procedural prophylaxis. For children with mild type 1 VWD, the most common form, a preoperative trial of DDAVP with monitoring of VWF activity levels is a standard strategy to confirm responsiveness and guide dosing before an elective procedure [2]. The nursing role involves verifying that this responsiveness testing has been completed, ensuring the drug is administered at the correct time preoperatively (typically 30-60 minutes prior), and monitoring for adverse effects such as hyponatremia due to the drug's antidiuretic effect, which requires postoperative fluid restriction. In more severe subtypes of VWD, where DDAVP may be ineffective, the nursing intervention would shift to coordinating the administration of VWF-containing factor concentrates, but the core principle of proactive, systemic hemostatic coverage remains identical [3,4]. The successful management of extensive dental procedures in patients with VWD, including full-arch clearances and implant placements, has been documented when meticulous preoperative planning with hematologists and the use of appropriate factor replacement or DDAVP is implemented .
References (research sources)
[1]
Managing Oral Surgery in von Willebrand Disease: Lessons from a Challenging Case.Research articleAscani G, Ranalli P, Azzuni F, Benfatto S, Romano M, Di Nobile E. (2025) · DOI: 10.4317/jced.62620
[2]
Procedural outcomes in children with mild type 1 von Willebrand disease.Research articleHeery S, Zimowski K, Mason SF, White MH, DiGiandomenico S, Trotter C, Sidonio RF, Brown MC. (2024) · DOI: 10.1016/j.rpth.2024.102334
[3]
Bleeding Risk Assessment and Management Strategies for Elective Surgery and Invasive Procedures: A Systematic Review.Meta-analysis/systematic reviewAlsagga H, Bassiony MI, Eladani OMB, Elhadi Elmana B, Alagha Z, Suliman Y, Ahmed H, Mokhtar AE, Ahmed A. (2026) · DOI: 10.7759/cureus.108286
Preoperative Hemostasis in VWDManaging dental extraction in a child with von Willebrand disease
The standard of care for invasive procedures is preemptive hemostatic coverage. Administer desmopressin (DDAVP)30–60 minutes before surgery to transiently raise endogenous von Willebrand factor and factor VIII levels.
A test dose of DDAVP should be given prior to the procedure to confirm a sufficient hemostatic response, as not all subtypes of VWD respond.
Caution
Avoid aspirin and NSAIDs. Do not use hydrogen peroxide rinses as they can disrupt clot formation. Postoperative antifibrinolytics like tranexamic acid may be prescribed to stabilize the clot.
von Willebrand disease — An inherited bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor, impairing platelet adhesion.
Desmopressin (DDAVP) — A synthetic hormone that stimulates endothelial cells to release stored von Willebrand factor and factor VIII.
von Willebrand factor — A plasma protein that mediates platelet adhesion to injured vessel walls and protects factor VIII from degradation.
Dental extraction hemostasis — A high-risk procedure for bleeding due to vascular oral mucosa and fibrinolytic enzymes in saliva.